PAR

2.04%

24.0¢ paradigm biopharmaceuticals limited..

Sass, page-68

First 68 Last

Share
Profile

Follow
Luckyphil1

1,489 Posts.

290

16/09/21

07:09

Post #: 56100804
Share

Originally posted by WRpar20: ↑

Luckyphil1

As a governance consultant in your prior life, what do you think about Warren Buffet being CEO and a Chair of Berkshire Hathaway? Did that not meet your strict governance requirements because it hasn't seemed to be an issue for the eighth largest public company in the world having seen market beating returns almost every year since inception... I have raised this point before and been called out as Paul Rennie himself by our infamous troll Gan_Gans - the most jaded shareholder on our register with nothing positive to say yet still has his sentiment as buy and his disclosure as held. Rumour has it that he bough his entry PARcel at $4.20 in January last year.... Anyway, now PR is no Buffet but it shows that dual hatting occurs in the largest and most successful companies in the world and has not caused any problems for the shareholders. Why is it fine for a company with a market cap greater than a quarter of the whole ASX combined but not for a mid cap on an exchange which takes up only 2% of the worlds total equities...

What would a really good chair want for their shareholders? 3 months of market beating returns? 1 year? 2 years? 3 years? Maybe his vision is so far beyond 1,2 & 3 year time horizons for this share price and therefore and that attempting to get quick wins with the share price seems pointless and potentially even damaging long term. The man himself is the largest holder in the company. Out of all of us, if this flops it affects him the most via a dollar value.

By all means, if you think there are legitimate concerns then that is fine to raise them. Obviously a few of you have concern with this, but if the shareprice was going the other way, I think you would have no qualms about his ability to dual hat. Just happens to be that the shareprice isnt going up but how much of the shareprice move can you actually contribute to the fact that he is CEO and Chair... If he wasn't Chair, would this really have affected the fact that the FDA had questions on our IND...?

DYOR, IMO etc etc

Expand

looks like your views are locked in so no point discussing. Buffett is a brilliant exception although he is surrounded by brilliamt minds and i imagine he listens to them. PR is no buffett and his many governance missteps could have been averted by having checks and balances.

PAR Price at posting: $1.93 Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 68 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 24.0¢		Change -0.005(2.04%)		Mkt cap ! $83.98M

Open	High	Low	Value	Volume
25.0¢	25.5¢	24.0¢	$202.2K	814.1K

Buyers (Bids)

No.	Vol.	Price($)
5	181098	24.0¢

Sellers (Offers)

Price($)	Vol.	No.
25.0¢	118621	5

View Market Depth

No.	Vol.	Price($)
5	181098	0.240
4	27745	0.235
1	25000	0.230
5	41756	0.225
7	59930	0.220

Price($)	Vol.	No.
0.250	74601	4
0.255	50000	1
0.260	21333	2
0.265	69367	4
0.270	53000	2

Last trade - 16.10pm 15/11/2024 (20 minute delay)

PAR (ASX) Chart

Sass, page-68

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sass, page-68

Top Stories

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News